GlassScriptPhysician profile
Jeremy Dock
NPI 1912604851
$1,828.32
in general payments reported to CMS, 2019-2025
7 companies · $1,454 in 2025
The $1,454 reported for 2025 was more than what 93% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $83.30 · 2023: $266 · 2024: $25.26 · 2025: $1,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Entertainment: $1,182 · Food and Beverage: $478 · Travel and Lodging: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Entertainment | $1,182.17 |
| Food and Beverage | $477.85 |
| Travel and Lodging | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Orthodontics Corporation | $1,430.70 | 2025 | Radiance, Empower-Ceramic, Master Series |
| Lightforce Orthodontics, INC. | $138.75 | 2022-2023 | |
| Patterson Companies, INC. | $78.27 | 2023 | |
| Ormco Corporation | $66.09 | 2023 | Spark |
| Nobel Biocare USA | $66.08 | 2023 | Nobelactive |
| Solventum Corporation | $25.26 | 2024 | 3m |
| Envista Holdings Corporation | $23.17 | 2025 | Spark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Dock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.